FIELD: medical practice. SUBSTANCE: means is offered in form of germanium-organic compound for treatment of neurologic diseases. Pharmacologic action of offered means includes analgetic, immunomodulating antiinflammatory and antiviral effects. EFFECT: attained need effect within shorter terms with prolonged remission of chronic diseases. 3 cl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF MOUTH MUCOSA CAVITY AND GINGIVAE ILLNESSES | 1999 |
|
RU2139730C1 |
PREPARATION FOR TREATMENT AND PROPHYLAXIS OF SICKNESS IN MAMMALS, BIRDS AND REPTILES | 1997 |
|
RU2093177C1 |
BIOLOGICALLY-ACTIVE ADDITIVE "ANID" | 1999 |
|
RU2141777C1 |
IMMUNE CORRECTION METHOD FOR TREATING PATIENTS SUFFERING FROM CHRONIC DISEASES | 1999 |
|
RU2150284C1 |
METHOD FOR COMPLEX EXPOSURE ON NEURAL-REFLEX ITCHING MECHANISMS IN PATIENTS WITH ATOPIC DERMATITIS | 2013 |
|
RU2523634C1 |
METHOD OF SURFACE CONTROLLED ACUPUNCTURE | 2017 |
|
RU2697326C2 |
METHOD FOR REHABILITATION OF PATIENTS WITH ALCOHOL POLYNEUROPATHY | 2015 |
|
RU2594252C1 |
METHOD OF TREATING PATIENTS WITH CERVICAL AND/OR LUMBAR SPINE DORSOPATHY | 2015 |
|
RU2602043C1 |
METHOD OF TREATING AUTISM SPECTRUM DISORDERS | 2019 |
|
RU2716754C2 |
METHOD OF REHABILITATION OF MULTIPLE SCLEROSIS PATIENTS WITH DISORDERED MOTOR FUNCTION | 2008 |
|
RU2393843C1 |
Authors
Dates
1999-10-20—Published
1999-03-24—Filed